PharmatrophiX is developing a series of small molecule compounds called "neurotrophin mimetics" that mimic the function of neurotrophins. Neurotrophins are naturally occurring proteins that are responsible for the development, health and survival of neurons. These mimetics are the most promising compounds to date that target the degeneration caused by the toxic protein beta-amyloid which kill neurons, impair memory and may be the cause of Alzheimer's disease... ADDF's Press Release -
Monday, March 10, 2008
Pharmatrophix Alzheimer's Drug Discovery Foundation to Develop Drugs to Prevent Neurodegenerative Disease
January 22, 2008 - The Alzheimer's Drug Discovery Foundation (ADDF) announced that it is providing a biotechnology founder's grant of $300,000 to PharmatrophiX, a start-up biotechnology company dedicated to developing a drug to prevent neuronal degeneration and improve brain function.
